0
* Risky CAR-T treatment associated with four deaths this year * Companies, fresh off CAR-T cancer success, pour money into autoimmune disease trials * About 150 lupus-focused CAR-T trials are underway
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)